Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News HTG Molecular Diagnostics Inc HTGMQ

HTG Molecular Diagnostics, Inc. is a life science company. The Company is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The Company is engaged in the sales of its HTG EdgeSeq system and integrated next-generation sequencing-based (NGS-based) HTG EdgeSeq research use only (RUO) assays and... see more

Recent & Breaking News (GREY:HTGMQ)

46 Biggest Movers From Yesterday

Benzinga.com  April 10, 2019

The Daily Biotech Pulse: Blueprint Medicine Expedites Clinical Programs, Eyepoint Offering, Precision Biosciences IPO

Benzinga.com  March 28, 2019

HTG Introduces the HTG EdgeSeq Mouse mRNA Tumor Response Panel

GlobeNewswire March 27, 2019

The Daily Biotech Pulse: Tonix Gets European Patent, EC Nod For Roche, Insys Earnings

Benzinga.com  March 8, 2019

HTG Molecular Diagnostics Reports Full Year 2018 Results

GlobeNewswire March 7, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs

Benzinga.com  March 3, 2019

HTG Molecular Diagnostics to Announce Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results and Host Conference Call on Thursday, March 7

GlobeNewswire February 21, 2019

HTG Molecular to Present Corporate Overview at the Cowen & Company 39th Annual Health Care Conference

GlobeNewswire February 21, 2019

HTG Molecular Announces an Amendment and Extension to its Precision Diagnostic Partnership (PDP) Two

GlobeNewswire February 20, 2019

HTG Molecular Appoints Dr. Joseph Sparano as Lead of Its Clinical Scientific Advisory Board for Breast Cancer Program

GlobeNewswire January 23, 2019

HTG Launches HTG EdgeSeq Reveal

GlobeNewswire January 16, 2019

HTG Molecular Announces Executive Transition Plan

GlobeNewswire January 14, 2019

HTG Announces Preliminary Full Year 2018 Unaudited Revenue of Approximately $21.5 Million

GlobeNewswire January 7, 2019

24 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  December 28, 2018

A Peek Into The Markets: US Stock Futures Climb Ahead Of Economic Reports

Benzinga.com  December 28, 2018

HTG Establishes a French Subsidiary to Support Expanding Growth 

GlobeNewswire December 18, 2018

TATAA Biocenter Expands Its Next-Generation Sequencing Offerings with HTG Molecular Diagnostics' Unique HTG EdgeSeq System

GlobeNewswire December 5, 2018

Factors of Influence in 2018, Key Indicators and Opportunity within Dillard's, Biohaven Pharmaceutical Holding, HTG Molecular Diagnostics, Strongbridge Biopharma, Myriad Genetics, and Beazer Homes — New Research Emphasizes Economic Growth

GlobeNewswire November 27, 2018

HTG Molecular Presenting at Upcoming Healthcare Conferences

GlobeNewswire November 12, 2018

HTG Molecular Diagnostics Reports Third Quarter 2018 Results

GlobeNewswire November 8, 2018